Company / R&D per Share
Avanos Medical, Inc. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.50
FY2025
5-year range
$0.50 / $0.64
FY2021-FY2025
Trend
-12.0%
vs FY2024
Sector context
#89 of 108
Health Care
What the data says
Avanos Medical, Inc.'s r&d per share of $0.50 is lower than 82% of companies in the Health Care sector (FY2025). R&D per Share has declined for 7 consecutive years, from $0.88 in FY2018 to $0.50 in FY2025.
Based on SEC 10-K filings.
0.50 in FY2025 with a 5-year CAGR of -7.2%.
Declined from $0.59 to $0.50 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -7.2%
- 5-Year CAGR
- -7.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 108This company $0.50 Sector average $2.07
▼
-75.8% below sector average
Key checks
Key Insights
- Avanos Medical, Inc.'s r&d per share has declined for 7 consecutive years.
- In FY2025, r&d per share decreased 12.0% year-over-year.
- Ranks #89 out of 108 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.50 | -12.0% |
| FY2024 | $0.57 | -3.2% |
| FY2023 | $0.59 | -6.1% |
| FY2022 | $0.63 | -1.7% |
| FY2021 | $0.64 | -12.3% |
| FY2020 | $0.73 | -8.3% |
| FY2019 | $0.79 | -9.8% |
| FY2018 | $0.88 | +8.2% |
| FY2017 | $0.81 | -1.0% |
| FY2016 | $0.82 | +38.9% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026